全球螢光雜合反應探針市場規模、佔有率、趨勢和成長分析報告（2026-2034）

螢光原位雜合反應(FISH) 探針市場預計將從 2025 年的 17.2 億美元成長到 2034 年的 34 億美元，2026 年至 2034 年的複合年成長率為 7.89%。

隨著分子診斷技術在醫學和遺傳學研究中的重要性日益凸顯，全球螢光原位雜合反應（FISH）探針市場正在不斷擴張。 FISH探針用於檢測和定位細胞內特定的DNA或RNA序列，從而實現對遺傳異常的精準識別。這項技術廣泛應用於癌症診斷、產前檢測和細胞遺傳學研究。

市場促進因素之一是對精準基因檢測和個人化醫療日益成長的需求。醫療專業人員正依賴FISH技術來檢測染色體異常並識別疾病相關的遺傳標記。此外，螢光成像技術和探針設計的進步正在提高基於FISH的診斷測試的靈敏度和可靠性。

展望未來，FISH探針市場可望受益於分子診斷和基因組學研究的持續發展。自動化成像系統和先進實驗室技術的整合有望進一步提高檢測效率。隨著基因檢測在臨床應用中日益普及，全球對螢光雜合反應探針的需求預計將會成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球螢光雜合反應探針市場：依產品類型分類

• 市場分析、洞察與預測
• DNA探針
• RNA探針
• 其他

第5章 全球螢光雜合反應探針市場：依應用分類

• 市場分析、洞察與預測
• 癌症診斷
• 遺傳性疾病
• 感染疾病診斷
• 其他

第6章 全球螢光雜合反應探針市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院/診斷檢查室
• 研究和學術機構
• 製藥和生物技術公司

第7章 全球螢光雜合反應探針市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abnova Corp
  • LGC Biosearch Technologies
  • Oxford Gene Technology IP Ltd
  • Horizon Diagnostics
  • Agilent Technologies Inc
  • Perkinelmer Inc
  • Genemed Biotechnologies Inc
  • Biocare Medical LLC
  • Qiagen（Exiqon A/S）
  • Thermo Fisher Scientific Inc

The Fluorescence In Situ Hybridization Probe Market size is expected to reach USD 3.40 Billion in 2034 from USD 1.72 Billion (2025) growing at a CAGR of 7.89% during 2026-2034.

The Global Fluorescence In Situ Hybridization (FISH) Probe Market is expanding as molecular diagnostic technologies become increasingly important in medical and genetic research. FISH probes are used to detect and localize specific DNA or RNA sequences within cells, enabling precise identification of genetic abnormalities. This technique is widely used in cancer diagnostics, prenatal testing, and cytogenetic research.

One of the major drivers of the market is the growing demand for accurate genetic testing and personalized medicine. Healthcare professionals rely on FISH technology to detect chromosomal abnormalities and identify disease-related genetic markers. Additionally, advancements in fluorescence imaging and probe design have improved the sensitivity and reliability of FISH-based diagnostic tests.

Looking ahead, the FISH probe market is expected to benefit from continued developments in molecular diagnostics and genomic research. The integration of automated imaging systems and advanced laboratory technologies may further enhance testing efficiency. As genetic testing becomes more widely adopted in clinical practice, the demand for fluorescence in situ hybridization probes is projected to increase globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• DNA Probe
• RNA Probe
• Others

By Application

• Cancer Diagnosis
• Genetic Disorders
• Infectious Disease Diagnosis
• Others

By End User

• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Abnova Corp, LGC Biosearch Technologies, Oxford Gene Technology IP Ltd, Horizon Diagnostics, Agilent Technologies Inc, Perkinelmer Inc, Genemed Biotechnologies Inc, Biocare Medical LLC, Qiagen Exiqon AS, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. DNA Probe Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. RNA Probe Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cancer Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Genetic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Infectious Disease Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abnova Corp
  • 9.2.2 LGC Biosearch Technologies
  • 9.2.3 Oxford Gene Technology IP Ltd
  • 9.2.4 Horizon Diagnostics
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Perkinelmer Inc
  • 9.2.7 Genemed Biotechnologies Inc
  • 9.2.8 Biocare Medical LLC
  • 9.2.9 Qiagen (Exiqon A/S)
  • 9.2.10 Thermo Fisher Scientific Inc